Brind.

Recursion Pharmaceuticals and Anika Therapeutics were noted to be operating in the Medical - Biomedical and Genetics industry.

1 report, 1 independent Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Recursion Pharmaceuticals and Anika Therapeutics were noted to be operating in the Medical - Biomedical and Genetics industry.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • ZacksRecursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock? Recursion Pharmaceuticals (RXRX) shares soared 5.8% in the last trading session to close at $5.84. The move was backe